ENTERA BIO LTD (ENTX) Stock Price & Overview
NASDAQ:ENTX • IL0011429839
Current stock price
The current stock price of ENTX is 1.27 USD. Today ENTX is down by -3.79%. In the past month the price decreased by -16.45%. In the past year, price decreased by -32.45%.
ENTX Key Statistics
- Market Cap
- 58.242M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.13
- Dividend Yield
- N/A
ENTX Stock Performance
ENTX Stock Chart
ENTX Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ENTX. When comparing the yearly performance of all stocks, ENTX is a bad performer in the overall market: 90.96% of all stocks are doing better.
ENTX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ENTX. While ENTX has a great health rating, there are worries on its profitability.
ENTX Earnings
ENTX Forecast & Estimates
7 analysts have analysed ENTX and the average price target is 10.2 USD. This implies a price increase of 703.15% is expected in the next year compared to the current price of 1.27.
For the next year, analysts expect an EPS growth of -14.24% and a revenue growth -69.78% for ENTX
ENTX Groups
Sector & Classification
ENTX Financial Highlights
Over the last trailing twelve months ENTX reported a non-GAAP Earnings per Share(EPS) of -0.13. The EPS increased by 50% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -61.93% | ||
| ROE | -70.77% | ||
| Debt/Equity | 0 |
ENTX Ownership
ENTX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.8 | 388.432B | ||
| AMGN | AMGEN INC | 16.04 | 197.413B | ||
| GILD | GILEAD SCIENCES INC | 16.4 | 179.993B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.21 | 119.226B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.95 | 78.843B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.01 | 41.564B | ||
| INSM | INSMED INC | N/A | 30.069B | ||
| BIIB | BIOGEN INC | 11.29 | 26.644B | ||
| NTRA | NATERA INC | N/A | 26.624B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.95 | 23.498B | ||
| MRNA | MODERNA INC | N/A | 20.758B | ||
| EXAS | EXACT SCIENCES CORP | 340.74 | 19.77B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 18.798B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ENTX
Company Profile
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. The firm developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.
Company Info
IPO: 2018-06-28
ENTERA BIO LTD
Hadassah / Jerusalem Bio, Park, 5th Floor
JERUSALEM 9112002 IL
CEO: Spiros Jamas
Employees: 20
Phone: 97225327151
ENTERA BIO LTD / ENTX FAQ
What does ENTX do?
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. The firm developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.
Can you provide the latest stock price for ENTERA BIO LTD?
The current stock price of ENTX is 1.27 USD. The price decreased by -3.79% in the last trading session.
Does ENTERA BIO LTD pay dividends?
ENTX does not pay a dividend.
What is the ChartMill technical and fundamental rating of ENTX stock?
ENTX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the Price/Earnings (PE) ratio of ENTERA BIO LTD (ENTX)?
ENTERA BIO LTD (ENTX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.13).
What is the market capitalization of ENTX stock?
ENTERA BIO LTD (ENTX) has a market capitalization of 58.24M USD. This makes ENTX a Micro Cap stock.
What is the next earnings date for ENTX stock?
ENTERA BIO LTD (ENTX) will report earnings on 2026-03-27, after the market close.